Common Contracts
4 similar Limited Liability Company Agreement contracts by Theravance Biopharma, Inc., Theravance Inc
EX-10.4 7 a14-10828_1ex10d4.htm EX-10.8 LIMITED LIABILITY COMPANY AGREEMENT OF LABA ROYALTY SUB LLCLimited Liability Company Agreement • May 5th, 2020 • Delaware
THIS LIMITED LIABILITY COMPANY AGREEMENT, dated as of April 17, 2014 (together with the schedules attached hereto, as the same may be amended or otherwise modified from time to time, this “Agreement”) of LABA ROYALTY SUB LLC, a Delaware limited liability company (the “Company”), is entered into by Theravance, Inc., a Delaware corporation, as the initial sole equity member (together with its successors and assigns in such capacity pursuant to Section 21 hereof, the “Member”) of the Company.
AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF TRIPLE ROYALTY SUB II LLCLimited Liability Company Agreement • March 4th, 2020 • Theravance Biopharma, Inc. • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT, dated as of February 28, 2020 (together with the schedules and exhibit attached hereto, as the same may be amended or otherwise modified from time to time, this “Agreement”), of Triple Royalty Sub II LLC, a Delaware limited liability company (the “Company”), is entered into by Theravance Biopharma R&D, Inc. (“Theravance Biopharma R&D”), a Cayman Islands exempted company, as the initial sole equity member (together with its successors and assigns in such capacity pursuant to Section 22 hereof, the “Member”) of the Company.
AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT OF TRIPLE ROYALTY SUB LLCLimited Liability Company Agreement • December 3rd, 2018 • Theravance Biopharma, Inc. • Pharmaceutical preparations • Delaware
THIS AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT, dated as of November 30, 2018 (together with the schedules and exhibit attached hereto, as the same may be amended or otherwise modified from time to time, this “Agreement”), of Triple Royalty Sub LLC, a Delaware limited liability company (the “Company”), is entered into by Theravance Biopharma R&D, Inc. (“Theravance Biopharma R&D”), a Cayman Islands exempted company, as the initial sole equity member (together with its successors and assigns in such capacity pursuant to Section 22 hereof, the “Member”) of the Company.
LIMITED LIABILITY COMPANY AGREEMENT OF LABA ROYALTY SUB LLCLimited Liability Company Agreement • April 21st, 2014 • Theravance Inc • Pharmaceutical preparations • Delaware
THIS LIMITED LIABILITY COMPANY AGREEMENT, dated as of April 17, 2014 (together with the schedules attached hereto, as the same may be amended or otherwise modified from time to time, this “Agreement”) of LABA ROYALTY SUB LLC, a Delaware limited liability company (the “Company”), is entered into by Theravance, Inc., a Delaware corporation, as the initial sole equity member (together with its successors and assigns in such capacity pursuant to Section 21 hereof, the “Member”) of the Company.
